Floatz logo

377 assets in Pancreatic Neoplasm

Therapeutic assets addressing Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
mrg007
Pancreatic Neoplasm
ArriVent BioPharma, Inc.P1C (36)
ngm438
Pancreatic Neoplasm
NGM Biopharmaceuticals, IncP1C (36)
ngm831
Pancreatic Neoplasm
NGM Biopharmaceuticals, IncP1C (36)
Nisevokitug
Pancreatic Neoplasm
Kimberly Perez, MDP2C (36)
np137
Pancreatic Neoplasm
Aram HezelP1C (36)
Nuv-868
Pancreatic Neoplasm
Nuvation Bio Inc.P1C (36)
Palbociclib
Pancreatic Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1C (36)
Pcna Inhibitor Aoh1996
Pancreatic Neoplasm
City of Hope Medical CenterP1C (36)
pf-08046876
Pancreatic Neoplasm
PfizerP1C (36)
Phn-012
Pancreatic Neoplasm
Pheon TherapeuticsP1C (36)
Piflufolastat
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1C (36)
Pitavastatin
Pancreatic Neoplasm
University of California, IrvineP1C (36)
P-Muc1C-Allo1 Car-T Cells
Pancreatic Neoplasm
Poseida Therapeutics, Inc.P1C (36)
pt0511
Pancreatic Neoplasm
PAQ Therapeutics, Inc.P1C (36)
Ptm-101
Pancreatic Neoplasm
PanTher TherapeuticsP1C (36)
qlc1101
Pancreatic Neoplasm
Qilu Pharmaceutical Co., Ltd.P1C (36)
Rimiducid
Pancreatic Neoplasm
Poseida Therapeutics, Inc.P1C (36)
Rmc-4630
Pancreatic Neoplasm
The Netherlands Cancer InstituteP1C (36)
Rmc-5127
Pancreatic Neoplasm
Revolution Medicines, Inc.P1C (36)
Rsc-1255
Pancreatic Neoplasm
RasCal Therapeutics, Inc.P1C (36)
Son-Dp
Pancreatic Neoplasm
Qurgen Inc.P1C (36)
Sotevtamab
Pancreatic Neoplasm
ImmunityBio, Inc.P1C (36)
Sysa1801 For
Pancreatic Neoplasm
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1C (36)
Tamibarotene
Pancreatic Neoplasm
Nagoya UniversityP1/2C (36)
Telisotuzumab Adizutecan
Pancreatic Neoplasm
AbbVieP1C (36)
Tgfβ-B-15 Peptide
Pancreatic Neoplasm
Inna Chen, MDP1C (36)
Tti 101
Pancreatic Neoplasm
Washington University School of MedicineP1C (36)
u87 car-t
Pancreatic Neoplasm
Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdP1C (36)
Ucmym802
Pancreatic Neoplasm
UTC Therapeutics Inc.P1C (36)
Ulixertinib
Pancreatic Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1C (36)
Vcn-01
Pancreatic Neoplasm
University of PennsylvaniaP1C (36)
Wm-A1-3389
Pancreatic Neoplasm
Wellmarker BioP1C (36)
Zunsemetinib
Pancreatic Neoplasm
Washington University School of MedicineP1C (36)
177lu-ctr-fapi
Pancreatic Neoplasm
Yan XingEarly P1C (33)
[177Lu]Lu-HT547
Pancreatic Neoplasm
Hua PangEarly P1C (33)
[⁶⁸Ga]Ga-HT547
Pancreatic Neoplasm
Hua PangEarly P1C (33)
68Ga-NODAGA-SNA006
Pancreatic Neoplasm
SmartNuclide BiopharmaEarly P1C (33)
Anti-Ex02 Car T Cells
Pancreatic Neoplasm
Zhang Xiaofeng,MDEarly P1C (33)
es502
Pancreatic Neoplasm
Ruijin HospitalEarly P1C (33)
[Ga-68]Mtp220
Pancreatic Neoplasm
Qiubai LiEarly P1C (33)
gc203 til
Pancreatic Neoplasm
Shanghai Juncell TherapeuticsEarly P1C (33)
im92 car-t cells
Pancreatic Neoplasm
Beijing Immunochina Medical Science & Technology Co., Ltd.Early P1C (33)
Ketorolac
Pancreatic Neoplasm
Andrew Hendifar, MDEarly P1C (33)
R130
Pancreatic Neoplasm
Shanghai Yunying Medical TechnologyEarly P1C (33)
Semaglutide
Pancreatic Neoplasm
University of ArizonaEarly P1C (33)
Sj-Neo006
Pancreatic Neoplasm
Jinling Hospital, ChinaEarly P1C (33)
Hucart-Meso Cells
Pancreatic Neoplasm
University of PennsylvaniaP1D (31)
Tovorafenib
Pancreatic Neoplasm
Day One Biopharmaceuticals, Inc.P1D (31)
bgt007h cell
Pancreatic Neoplasm
RenJi HospitalN/AD (30)
Showing 301 to 350 of 377 assets
PreviousPage 7 of 8Next